Literature DB >> 17050597

Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells.

Michael D Bobardt1, Udayan Chatterji, Suganya Selvarajah, Bernadette Van der Schueren, Guido David, Bruce Kahn, Philippe A Gallay.   

Abstract

Although the transport of human immunodeficiency virus type 1 (HIV-1) through the epithelium is critical for HIV-1 colonization, the mechanisms controlling this process remain obscure. In the present study, we investigated the transcellular migration of HIV-1 as a cell-free virus through primary genital epithelial cells (PGECs). The absence of CD4 on PGECs implicates an unusual entry pathway for HIV-1. We found that syndecans are abundantly expressed on PGECs and promote the initial attachment and subsequent entry of HIV-1 through PGECs. Although CXCR4 and CCR5 do not contribute to HIV-1 attachment, they enhance viral entry and transcytosis through PGECs. Importantly, HIV-1 exploits both syndecans and chemokine receptors to ensure successful cell-free transport through the genital epithelium. HIV-1-syndecan interactions rely on specific residues in the V3 of gp120 and specific sulfations within syndecans. We found no obvious correlation between coreceptor usage and the capacity of the virus to transcytose. Since viruses isolated after sexual transmission are mainly R5 viruses, this suggests that the properties conferring virus replication after transmission are distinct from those conferring cell-free virus transcytosis through the genital epithelium. Although we found that cell-free HIV-1 crosses PGECs as infectious particles, the efficiency of transcytosis is extremely poor (less than 0.02% of the initial inoculum). This demonstrates that the genital epithelium serves as a major barrier against HIV-1. Although one cannot exclude the possibility that limited passage of cell-free HIV-1 transcytosis through an intact genital epithelium occurs in vivo, it is likely that the establishment of infection via cell-free HIV-1 transmigration is a rare event.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050597      PMCID: PMC1797244          DOI: 10.1128/JVI.01303-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.

Authors:  Aymeric de Parseval; Michael D Bobardt; Anju Chatterji; Udayan Chatterji; John H Elder; Guido David; Susan Zolla-Pazner; Michael Farzan; Tun-Hou Lee; Philippe A Gallay
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

2.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques.

Authors:  C J Miller; N J Alexander; S Sutjipto; S M Joye; A G Hendrickx; M Jennings; P A Marx
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

4.  Semen analysis in human immunodeficiency virus infection.

Authors:  J A Crittenden; D J Handelsman; G J Stewart
Journal:  Fertil Steril       Date:  1992-06       Impact factor: 7.329

5.  Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.

Authors:  Michael M Lederman; Ronald S Veazey; Robin Offord; Donald E Mosier; Jason Dufour; Megan Mefford; Michael Piatak; Jeffrey D Lifson; Janelle R Salkowitz; Benigno Rodriguez; Andrew Blauvelt; Oliver Hartley
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

6.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

Authors:  S M Wolinsky; C M Wike; B T Korber; C Hutto; W P Parks; L L Rosenblum; K J Kunstman; M R Furtado; J L Muñoz
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

7.  Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells.

Authors:  N Yahi; S Baghdiguian; H Moreau; J Fantini
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

Authors:  J M Harouse; S Bhat; S L Spitalnik; M Laughlin; K Stefano; D H Silberberg; F Gonzalez-Scarano
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

9.  Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Authors:  Christopher D Pilcher; Hsiao Chuan Tien; Joseph J Eron; Pietro L Vernazza; Szu-Yun Leu; Paul W Stewart; Li-Ean Goh; Myron S Cohen
Journal:  J Infect Dis       Date:  2004-04-28       Impact factor: 5.226

10.  Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

Authors:  Michael D Bobardt; Patrick Salmon; Lianchun Wang; Jeffrey D Esko; Dana Gabuzda; Milan Fiala; Didier Trono; Bernadette Van der Schueren; Guido David; Philippe A Gallay
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  82 in total

1.  Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry.

Authors:  Natalia Cheshenko; Wen Liu; Lisa M Satlin; Betsy C Herold
Journal:  Mol Biol Cell       Date:  2007-06-06       Impact factor: 4.138

2.  Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.

Authors:  Nicholas J Mantis; Jana Palaia; Ann J Hessell; Simren Mehta; Zhiyi Zhu; Blaise Corthésy; Marian R Neutra; Dennis R Burton; Edward N Janoff
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

3.  Epstein-Barr virus transcytosis through polarized oral epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Joel M Palefsky
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 4.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

5.  Biology of HIV mucosal transmission.

Authors:  Li Wu
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

6.  Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells.

Authors:  Ping Chen; Benjamin K Chen; Arevik Mosoian; Thomas Hays; Michael J Ross; Paul E Klotman; Mary E Klotman
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

Review 7.  Plausibility of HIV-1 Infection of Oral Mucosal Epithelial Cells.

Authors:  M C Herzberg; A Vacharaksa; K H Gebhard; R A Giacaman; K F Ross
Journal:  Adv Dent Res       Date:  2011-04

8.  Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.

Authors:  Briana Nixon; Thomas Jandl; Ryan S Teller; Ekaterina Taneva; Yanhua Wang; Umadevi Nagaraja; Patrick F Kiser; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

Review 9.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 10.  HIV infection of the genital mucosa in women.

Authors:  Florian Hladik; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.